Pharco Pharmaceuticals, an Egyptian pharmaceutical company, has launched a new initiative called 'Vision for All' to combat glaucoma in Egypt. The program aims to provide free screenings and treatment for glaucoma, a leading cause of blindness, particularly in underserved communities.
According to the company's announcement, the initiative will focus on early detection and management of the disease, which affects millions worldwide. Pharco plans to partner with local hospitals and clinics to reach patients across multiple governorates.
Glaucoma is a chronic eye condition that damages the optic nerve, often due to high intraocular pressure. Without treatment, it can lead to irreversible vision loss. The 'Vision for All' program includes educational campaigns to raise awareness about the importance of regular eye exams.
Pharco's efforts align with global health goals to reduce preventable blindness. The company has not disclosed specific funding or patient targets for the initiative as of the launch date.
